4//SEC Filing
Holuka Eugene Myron 4
Accession 0001213900-18-012195
CIK 0001506251other
Filed
Sep 5, 8:00 PM ET
Accepted
Sep 6, 4:11 PM ET
Size
9.6 KB
Accession
0001213900-18-012195
Insider Transaction Report
Form 4
Holuka Eugene Myron
Director
Transactions
- Award
Options to Purchase Common Stock
2018-09-04+15,000→ 15,000 totalExercise: $1.62Exp: 2028-09-04→ Common Stock (15,000 underlying)
Holdings
- 2,415
Options to Purchase Common Stock
Exercise: $0.01Exp: 2024-04-14→ Common Stock (2,415 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $3.45Exp: 2027-09-13→ Common Stock (10,000 underlying) - 13,334
Options to Purchase Common Stock
Exercise: $12.00Exp: 2026-06-23→ Common Stock (13,334 underlying)
Footnotes (4)
- [F1]The options vest in full on the first anniversary of the vesting commencement date, September 4, 2019.
- [F2]The options vest in full on the first anniversary of the vesting commencement date, September 13, 2018.
- [F3]The option vested in 1/3 increments over a three year period with the first installment vesting on April 14, 2014.
- [F4]The options vested in full on the first anniversary of the date of grant.
Documents
Issuer
Citius Pharmaceuticals, Inc.
CIK 0001506251
Entity typeother
Related Parties
1- filerCIK 0001678292
Filing Metadata
- Form type
- 4
- Filed
- Sep 5, 8:00 PM ET
- Accepted
- Sep 6, 4:11 PM ET
- Size
- 9.6 KB